New Zealand markets closed

Farfetch Limited (FTCH)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
9.43+0.78 (+9.02%)
At close: 04:00PM EDT
9.30 -0.13 (-1.38%)
After hours: 07:48PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.99B
Enterprise value 2.70B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.63
Price/book (mrq)3.43
Enterprise value/revenue 1.18
Enterprise value/EBITDA 1.33

Trading information

Stock price history

Beta (5Y monthly) 3.14
52-week change 3-82.39%
S&P500 52-week change 3-8.83%
52-week high 353.77
52-week low 36.53
50-day moving average 39.60
200-day moving average 323.99

Share statistics

Avg vol (3-month) 311.6M
Avg vol (10-day) 310.99M
Shares outstanding 5338.46M
Implied shares outstanding 6N/A
Float 8322.73M
% held by insiders 14.69%
% held by institutions 195.14%
Shares short (30 May 2022) 423.25M
Short ratio (30 May 2022) 41.46
Short % of float (30 May 2022) 47.68%
Short % of shares outstanding (30 May 2022) 46.10%
Shares short (prior month 28 Apr 2022) 421.72M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 73.90%
Operating margin (ttm)-22.05%

Management effectiveness

Return on assets (ttm)-8.74%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)2.29B
Revenue per share (ttm)6.16
Quarterly revenue growth (yoy)6.10%
Gross profit (ttm)1.02B
EBITDA -328.03M
Net income avi to common (ttm)1.69B
Diluted EPS (ttm)-1.16
Quarterly earnings growth (yoy)43.60%

Balance sheet

Total cash (mrq)1.04B
Total cash per share (mrq)2.72
Total debt (mrq)752.31M
Total debt/equity (mrq)71.75
Current ratio (mrq)2.06
Book value per share (mrq)2.28

Cash flow statement

Operating cash flow (ttm)-336.91M
Levered free cash flow (ttm)-120.73M